Announcements Trials
Browse Landscape

Phase

Phase 2 22Phase 3 9Phase 4 2Phase NA 1Phase 2/3 1

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Gastrointestinal 1

Conditions

Nasopharyngeal Carcinoma 1Head and Neck Neoplasms 1

Interventions

Cisplatin 5lenvatinib 4Fentanyl 4Morphine 3Fluorouracil 3Docetaxel 3trametinib 2selpercatinib 2pralsetinib 2pembrolizumab 2nimotuzumab 2larotrectinib 2dabrafenib 2cabozantinib 2anlotinib 2Thyrotropin Alfa 2Saline Solution 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Norepinephrine 2Metformin 2Indocyanine Green 2Gabapentin 2Cinacalcet 2Cetuximab 2Carboplatin 2Benzydamine 2Acetaminophen 2xiaojin wan 1vandetanib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × nimotuzumab × Head & Neck × Clear all
NCT06879691 2025-03-17

A Trial of Nimotuzumab and Pinkiller Efficacy and Pain in Advanced Head and Neck Squamous Cell Carcinoma

Biotech Pharmaceutical Co., Ltd.

Phase 4 Active not recruiting
171 enrolled
Head & Neck

Head and Neck Neoplasms

NCT02293356 2015-08-19

Phase IV Clinical Trial of Nimotuzumab in the Treatment of Nasopharyngeal Carcinoma

Biotech Pharmaceutical Co., Ltd.

Phase 4 Unknown
2,000 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡